List of insiders holdings for Hoth Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | AIkido Pharma Inc. 10% Owner | 2021-02-16 17:43:09 | 1,130,674 0 | 1,130,674 | Form 13G |
| 2 | AHERN JAMES P. 10% Owner | 2019-03-04 16:22:07 | 750,000 0 | 750,000 | Form 3 |
| 3 | Poor Kevin Jess 10% Owner | 2019-03-04 16:32:08 | 750,000 0 | 750,000 | Form 4 |
| 4 | Johns Stefanie Chief Scientific Officer | 2022-03-18 16:15:47 | 250,000 0 | 250,000 | Form 4 |
| 5 | Knie Robb CEO and President | 2025-01-15 16:15:55 | 100,000 0 | 100,000 | Form 4 |
| 6 | Springer Graig Director | 2025-01-15 16:15:06 | 0 70,000 | 70,000 | Form 4 |
| 7 | Briones David S. Chief Financial Officer | 2019-03-07 16:33:21 | 50,000 0 | 50,000 | Form 4 |
| 8 | MATS VADIM Director | 2021-02-01 16:54:17 | 33,000 0 | 33,000 | Form 4 |
| 9 | Linsley Wayne Director | 2024-08-21 16:15:02 | 25,000 0 | 25,000 | Form 4 |
| 10 | Sarnoff David Director | 2024-08-21 16:15:05 | 25,000 0 | 25,000 | Form 4 |
| 11 | Pavell Jeff Director | 2024-08-21 16:15:07 | 25,000 0 | 25,000 | Form 4 |
| 12 | EITNER MATTHEW D. 10% Owner | 2021-02-16 16:54:46 | 18,750 0 | 18,750 | Form 13G |
| 13 | RICE KENNETH L JR Director | 2020-07-23 16:34:00 | 15,000 0 | 15,000 | Form 4 |
| 14 | Hayes Anthony Former Director Director | 2021-02-16 17:38:29 | 0 0 | 0 | Form 4/A |
| 15 | Camarra Christopher Michael Director | 2025-05-21 17:30:18 | 0 0 | 0 | Form 3 |